Letybo (letibotulinumtoxinA-wlbg) is now available for the temporary improvement in the appearance of moderate to severe ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Ruxolitinib 1.5% cream significantly reduces pruritus and lesion severity among adults with prurigo nodularis for up to 12 weeks of treatment.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

RFK Jr's cuts included Dr John Howard, the head of NIOSH's World Trade Center Health Program for 9/11 survivors and first responders.

Pertussis cases are happening more frequently as DTaP vaccination rates decrease, with Louisiana reporting 110 cases in 2025 so far.

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.

Multiple unvaccinated children showed signs of vitamin A toxicity after RFK Jr promoted using it to treat and prevent measles infection.

The FDA and CDC, divisions of the HHS, are expected to lose as much as 1 in 5 employees in new cuts overseen by RFK Jr.